APA (7th ed.) Citation

Verbeek, T. C. A. I., Vrenken, K. S., Arentsen-Peters, S. T. C. J. M., Castro, P. G., van de Ven, M., van Tellingen, O., . . . Stam, R. W. (2024). Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia. Communications Biology, 1. https://doi.org/10.1038/s42003-024-06916-w

Chicago Style (17th ed.) Citation

Verbeek, Tamara C. A. I., Kirsten S. Vrenken, Susan T. C. J. M. Arentsen-Peters, Patricia Garrido Castro, Marieke van de Ven, Olaf van Tellingen, Rob Pieters, and Ronald W. Stam. "Selective Inhibition of HDAC Class IIA as Therapeutic Intervention for KMT2A-rearranged Acute Lymphoblastic Leukemia." Communications Biology 2024: 1. https://doi.org/10.1038/s42003-024-06916-w.

MLA (9th ed.) Citation

Verbeek, Tamara C. A. I., et al. "Selective Inhibition of HDAC Class IIA as Therapeutic Intervention for KMT2A-rearranged Acute Lymphoblastic Leukemia." Communications Biology, 2024, p. 1, https://doi.org/10.1038/s42003-024-06916-w.